Skip to main content
Aspira Pathlab & Diagnostics Limited logo

Aspira Pathlab & Diagnostics Limited — Investor Relations & Filings

Ticker · 540788 ISIN · INE500C01017 BSE.NS Human health and social work activities
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-05-23 Board/Management Inform…
Country IN India
Listing BSE.NS 540788

About Aspira Pathlab & Diagnostics Limited

https://www.aspiradiagnostics.com/

Aspira Pathlab & Diagnostics Limited provides integrated diagnostic services, specializing in pathology and radiology. The company offers a comprehensive range of medical tests, including clinical chemistry, hematology, microbiology, and molecular biology. Its radiology department provides imaging services such as digital X-rays, ultrasonography, and specialized scans. Aspira focuses on delivering accurate and timely results through automated laboratory systems and a network of collection centers. The service portfolio includes preventive health check-up packages tailored for individuals and corporate clients. By leveraging advanced medical technology and standardized processes, the company aims to support clinical decision-making and patient care. Key features include home sample collection and digital report access, enhancing convenience for its diverse customer base.

Recent filings

Filing Released Lang Actions
The Board approved the appointment of Mr. Vaibhav Odhekar as an Additional Executive Director for 5 years
Board/Management Information Classification · 94% confidence The document is an official notice submitted under SEBI (LODR) Regulations to the stock exchange announcing board decisions at a Board meeting held on May 23, 2026, including appointments of a Company Secretary & Compliance Officer, Internal Auditor, and an Additional Executive Director. This is a change in senior management and the board, matching the ‘Board/Management Information’ category.
2026-05-23 English
The disclosure regarding of Mrs. Neetu Maurya as a Company Secretary of the company with effect from 24.05.2026 was inadvertently filed under change in Control
Board/Management Information Classification · 92% confidence The document is a formal notification under SEBI LODR Regulation 30, detailing the Board of Directors’ approval of management appointments (Company Secretary & Compliance Officer, Internal Auditor, and Additional Executive Director). It announces changes in senior management, fitting the definition of a Board/Management Information filing.
2026-05-23 English
Appointment of Mrs. Neetu Maurya as Company Secretary of the Company With Effect From 24.05.2026
Board/Management Information Classification · 94% confidence The document is a SEBI (LODR) Regulation 30 disclosure filed with BSE/NSE, announcing the appointment of a Company Secretary & Compliance Officer, an Internal Auditor, and an Additional Executive Director. This is a corporate management change announcement, fitting the Board/Management Information category.
2026-05-23 English
Appointment of M/s. Vishal J Bhanushali & Associates, as an Internal Auditor for F.Y. 2026-27 of the Company
Board/Management Information Classification · 93% confidence The document is a formal disclosure under SEBI (LODR) Regulation 30 announcing the appointment of key personnel: a Company Secretary & Compliance Officer, an Internal Auditor, and an Additional Executive Director. It details board approvals, appointment dates, tenures, and profiles of the appointees. This fits the definition of "Board/Management Information" (Code: MANG) since it announces changes in the company's board and senior management.
2026-05-23 English
Integrated Financial Results as on March 31, 2026
Regulatory Filings Classification · 78% confidence The document is a formal BSE/NSE compliance filing under SEBI LODR Regulations (Reg. 30 & 33) titled “Outcome of the meeting of Board of Directors.” It notifies approval of audited financial results, attaches the auditor’s report, and discloses multiple board resolutions including key management appointments. It is not simply a standalone annual report or quarterly report, nor a press‐style earnings release, but a regulatory announcement encompassing board decisions and management changes. This falls under the general “Regulatory Filings” (RNS) category.
2026-05-23 English
Board Meeting outcome for Dated May 23, 2026
Regulatory Filings Classification · 83% confidence The document is a stock‐exchange filing under SEBI (LODR) Regulations. It discloses the outcome of the Board meeting, including audited standalone financial results, auditor’s report, and multiple board appointments (Company Secretary, Internal Auditor, Additional Director). It is not a full Annual Report (10‐K) or an Interim Report (IR) but a regulatory announcement containing financial results and governance changes. It fits the “Regulatory Filings” (RNS) category as a general compliance disclosure under listing obligations.
2026-05-23 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.